Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,324
Sort by:
In Vitro Toxicology Testing - Global Market Outlook (2016-2022)
US$ 4,150.00
According to Stratistics MRC, the Global In Vitro Toxicology Testing Market is accounted for $12.30 billion in 2015 and is expected to reach $32.45 billion by ... market growth. However, strict regulations and predictive ability of in vitro testing over in vivo testing are hampering the market. Growing drug discovery and ...
September 2016
133 pages
Lyme Disease Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Emerging Opportunities
US$ 3,480.00
... LabsIn addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Lyme disease tests. Also, the report examines the market applications of DNA Probes, Monoclonal ...
September 2016
203 pages
Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics) - Global Forecast to 2021
US$ 5,650.00
... subsegments: Cancer Immunotherapy Market, by Type Monoclonal Antibodies Cancer Vaccines Checkpoint Inhibitors Immunomodulators Cancer Immunotherapy Market, by Application Lung Cancer Breast Cancer Head and Neck Cancer Prostate Cancer Colorectal Cancer Melanoma Others Cancer Immunotherapy Market, by End ...
September 2016
142 pages
2016 Europe Cell Surface Markers: Country Volume and Sales Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers--France, Germany, Italy, Spain, UK
US$ 3,080.00
... cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country.RationaleThe use of surface marker identification ... report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries, including clinical significance and current ...
September 2016
125 pages
Europe Hematology and Flow Cytometry Instruments and Reagents: Supplier Sales and Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, New Technologies, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US
US$ 15,760.00
... regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests ... Current and Emerging Products - Analysis of current and emerging hematology and flow cytometry tests- Reagent and instrument sales forecasts by market segment- Instrument ...
September 2016
450 pages
2016 Germany Hospital Hematology and Flow Cytometry Markets
US$ 3,080.00
... a comprehensive analysis of the German hospital hematology and flow cytometry markets, including: Major issues pertaining to the German hematology and flow cytometry practice ... major hematology and flow cytometry tests performed in German hospitals. Annual placements and installed base estimates for major automated and semiautomated hematology ...
September 2016
233 pages
Hematology and Flow Cytometry Instruments and Reagents: Supplier Sales and Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, New Technologies, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US
US$ 27,600.00
... systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and ... Products Analysis of current and emerging hematology and flow cytometry tests Reagent and instrument sales forecasts by market segment Instrument placements and installed base by manufacturer ...
September 2016
700 pages
2016 UK Hospital Hematology and Flow Cytometry Markets
US$ 3,080.00
... presents a comprehensive analysis of the UK hospital hematology and flow cytometry markets, including: Major issues pertaining to the UK hematology and flow cytometry practice, as well ... major hematology and flow cytometry tests performed in UK hospitals. Annual placements and installed base estimates for major automated and semiautomated hematology analyzers ...
September 2016
235 pages
2016 US Hospital Hematology and Flow Cytometry Markets
US$ 5,440.00
... presents a comprehensive analysis of the US hospital hematology and flow cytometry markets, including: Major issues pertaining to the US hematology and flow cytometry practice, as well ... major hematology and flow cytometry tests performed in US hospitals. Annual placements and installed base estimates for major automated and semiautomated hematology analyzers ...
September 2016
248 pages
Global Blood Transfusion Market by Manufacturers, Regions, Type and Application, Forecast to 2021
US$ 3,480.00
... Market Segment by Applications, can be divided into Child Adult There are 13 Chapters to deeply display the global Blood Transfusion market. Chapter 1, to describe Blood Transfusion Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Blood Transfusion, with ...
September 2016
116 pages
Global Food Safety Testing Market Outlook 2021
US$ 1,400.00
... market is forecasted to grow at a CAGR of around 8% during 2017-2021. In the latest research report “Global Food Safety Testing Market Outlook 2021”, our analysts have studied the global food safety testing market in terms of contaminants and technology. The food safety testing market by contaminants is sub-divided ...
September 2016
115 pages
Asia - Self Monitoring of Blood Glucose (SMBG) (Test Strips, Lancet, Meter) Market and Forecast
US$ 1,100.00
... in order to achieve a specific level of glycemic control and to prevent hypoglycemia. Self-monitoring of blood glucose is a very lucrative business with enormous market opportunity ... maximum share of the SMBG market. iGATE RESEARCH report titled “Asia - Self Monitoring of Blood Glucose (SMBG) (Test Strips, Lancet, Meter) Market and ...
September 2016
123 pages
Global Blood Irradiation Sales Market by Manufacturers, Regions, Type and Application, Forecast to 2021
US$ 3,480.00
... the global Blood Irradiation Sales market. Chapter 1, to describe Blood Irradiation Sales Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Blood Irradiation Sales, with sales, revenue ...
September 2016
115 pages
Analyzing the Global Diabetes Market 2016
US$ 1,000.00
... for diabetes are analyzed in this section. We also look at diabetes epidemiology. Moving to the next section, we analyze the global diabetes market through a market overview and an analysis of the market by diabetes ...
September 2016
195 pages
US Breast Cancer Drug Market Outlook 2022
US$ 1,800.00
... Breast Cancer Drug Market Outlook 2022” Report Highlights: US Breast Cancer Tendencies US Breast Cancer Drug Market Outline US Breast Cancer Drug Market Dynamics Breast Cancer Risk Undercurrents US Breast Cancer Marketed Drugs Clinical Insight by Company & Patent Analysis US Breast Cancer Marketed ...
September 2016
130 pages
Exosome Diagnostic and Therapeutic Market by Application (Diagnostic and Therapeutic), Product (Instrument, Reagent and Software) and End-User (Cancer Institute, Hospital, Diagnostic Center, and Others) - Global Opportunity Analysis and Industry Forecasts, 2014-2022
US$ 5,540.00
... outlook of the market. Key market segments The world exosome diagnostic and therapeutic market is segmented into application, product, end user, and geography. MARKET BY APPLICATION Diagnostic Therapeutic MARKET BY PRODUCT Instrument ...
September 2016
115 pages
Ulcerative Colitis: KOL Insight
US$ 7,900.00
... UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs ... advantage. Update Bulletins include expert insight and analysis based on FirstWord analyst re-engagement with the KOLs after major events such as product ...
August 2016
Hepatitis C: KOL Insight
US$ 7,900.00
... options? Since the launch of Sovaldi (sofosbuvir; Gilead) in 2013, the hepatitis C (HCV) landscape has developed at a rapid pace. The focus has ... report reveals candid insights about the HCV landscape from 12 KOLs in North America and Europe. You’ll learn which treatments KOLs have confidence ... advantage. Update Bulletins include expert insight and analysis based on FirstWord analyst re-engagement with the KOLs after major events such as product ...
August 2016
Cancer/Tumor Profiling - Global Market Outlook (2016-2022)
US$ 4,150.00
... MRC, the Global Cancer/Tumor Profiling market is expected to grow from $23.04 billion in 2015 to reach $78.69 billion by 2022 with a CAGR of 19.2%. Increasing cases of cancer and the need ... cancer profiling industry leaders. Asia Pacific is expected to witness huge growth due to raising incidence of cancer in this region. Some of the key players in global Cancer/Tumor profiling market ...
August 2016
147 pages
